Quick context
Kisspeptin-10
临床研究关注 GnRH、LH 及生殖信号；并非普遍获批药物。
Published study protocols are research procedures with inclusion and exclusion criteria. They are not instructions for unsupervised use.
Back to all 64 profiles
Clinical research临床研究中WADA
Community protocol · Kisspeptin-10
Kisspeptin-10: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: KP-10 · Kisspeptin 112-121
Sources checked: 27 August 2026
重要安全与责任声明
本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Amounts, timing and cycles
Clinical research
Published study protocols are research procedures with inclusion and exclusion criteria. They are not instructions for unsupervised use.
Amount status
Trials use protocol-bound amounts and escalation; this does not create a safe community dose.
Profile evidence level: clinical.
Timing
Timing is set by each trial protocol and may differ substantially between studies.
No individual recommendation.
Cycle/duration
Duration is study-specific and ends according to protocol; long-term safety may remain unknown.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Open community source复配与 U-100 换算
复配计算器
For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.
复配计算器
Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.
Concentration
3,333.33 µg/ml
Calculated volume
0.06 ml
U-100 units
6 U
Calculated portions per vial
50
Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.
Mechanism and research questions
KISS1 receptor agonist influencing the reproductive hormone axis
Kisspeptin-10 is classified as “KISS1 receptor agonist influencing the reproductive hormone axis”. 临床研究关注 GnRH、LH 及生殖信号；并非普遍获批药物。 This describes the investigated pathway but does not validate a community use, amount, route or combination.
KISS1受体激活
这项研究考察激活KISS1受体如何控制上游激素信号,最终触发生殖激素的释放,类似于信号链开端的启动信号。临床研究中测量血液中的激素水平。
生育激素轴
研究人员研究控制生育能力的大脑与生殖器官之间的激素信号链,类似于接力赛中每种激素将信号传递给下一个环节。常见测量指标是月经或生殖周期中血液里的生殖激素水平。
神经内分泌信号传导
这项研究考察神经系统与激素分泌腺体之间如何相互沟通,类似于连接大脑与远端器官的双向电话线路。研究人员通常同时测量血液中的激素水平和神经系统活动标志物。
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
生育与性欲论坛
人们讨论与性欲或月经周期相关的激素信号肽的个人经历,常与已获批产品进行比较。这类经验分享是个体化的,无法替代医学评估或对照研究。
来源与纯度讨论
人们讨论哪些商家被认为更值得信赖,以及不同批次之间纯度检测结果的差异。这类社区评估基于有限的样本,无法替代对每一批次进行的独立实验室检测。
综合健康论坛
人们在此交流使用各类产品后情绪、睡眠和整体感受等更宽泛的健康印象,通常没有结构化的记录。这类笼统印象无法替代有针对性的临床检查。
Adverse effects and risk boundaries
- 生殖、血管活性或水分调节信号可影响激素轴、血压、心率、液体平衡及妊娠；风险高度取决于途径和适应证。
- Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
- A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
- 妊娠或生育计划、心血管疾病、电解质/液体紊乱及激素敏感性疾病需要针对适应证的医疗监督。
- Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
- Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
- 根据目标，可监测生命体征、液体平衡、电解质、生殖激素及明确定义的临床终点。
- Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
临床试验中
该物质正在接受临床研究,但尚未成为普遍获批的药品。
Published evidence
该物质目前正在结构化的人体临床试验中进行研究,尚未获得普遍批准。
Kisspeptin-10作用于KISS1受体,调控上游的GnRH信号传导,不同于直接作用于催产素受体的催产素。
Storage and stability
- The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
- Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
- Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
- U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
- Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
- Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
- Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
临床研究中
处于临床开发阶段，尚不是获批药物。
WADA 2026
This profile is marked as WADA-relevant. Check the original 2026 Prohibited List and the specific sport/route; a prohibition may cover an entire class or related agents.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
- Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
- Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
- Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
- Primary/technical sourceClinicalTrials.gov: kisspeptin research
- Primary/technical sourceWADA — 2026 Prohibited List
- Community referenceKisspeptin-10 — Peptide Dosing Protocols